Hospital News and Research

RSS

CIO Healthcare Summit to be sponsored by Zanett Healthcare

Zanett Healthcare is pleased to announce that it will sponsor the CIO Healthcare Summit, a leading gathering for CIOs, analysts and industry-thought leaders within healthcare information technology. The CIO Healthcare Summit will be held at the InterContinental Montelucia Resort in Scottsdale, Arizona on May 9-12, 2010.

19 Mar 2010

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.

19 Mar 2010

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Most kidney donors and recipients are in favor of exchanging personal health information that may influence success before scheduling a living organ donor transplant, while healthcare professionals are more reluctant, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

19 Mar 2010

White paper describes health and economic burden of diabetes on Americans

PositiveID Corporation announced today that it has published a white paper entitled “Fixing the Black Hole in Diabetes Management,” which describes the health and economic burden of diabetes on Americans and our economy.

19 Mar 2010

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

Roche today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for use of Tarceva(R) (erlotinib) as a maintenance therapy for people with advanced non-small cell lung cancer (NSCLC) and stable disease (cancer remains largely unchanged) after initial chemotherapy. The CHMP positive opinion clears the way for European Union approval and means that this group of patients may soon be able to benefit from earlier treatment with Tarceva.

19 Mar 2010

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.

19 Mar 2010

First Edition: March 19, 2010

The headlines reflect yesterday's flurry of activity as House Democratic Leaders unveiled their $940 billion health-care compromise bill and steamed toward a Sunday vote. All the while, Republican leaders plotted was to stall this progress and nullify the measure.

19 Mar 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps). A second study examined endoscopist experience using TER and its impact on polyp detection rates, concluding that polyp detection rates improved significantly with TER.

19 Mar 2010

New report on the state of U.S. mobile health market

CSMG, the strategy division of TMNG Global, a leading provider of professional services, products and services to the converging communications, media and entertainment industries, today released its report on the state of the U.S. mobile health market, entitled: mHealth: Taking the Pulse.

19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology and the American Heart Association to intervene on only the culprit vessel.

19 Mar 2010

Study shows that steroids target hemangioma stem cells

Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy - are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing. Since the 1960s, problematic hemangiomas have been treated with corticosteroids such as dexamethasone or prednisone.

19 Mar 2010

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Scientists at The Virginia Commonwealth University Medical Center found that an emphasis on compliance with non-pathogen specific infection control practices such as hand hygiene, efforts to reduce device-related infections and chlorhexidine bathing (a daily bath with the same antibacterial agent used by surgeons to "scrub in" before an operation), is successful in reducing rates of healthcare-associated methicillin-resistant Staphylococcus aureus.

19 Mar 2010

Postcard campaign: Staff request Ontario government to fund deficit of Brockville General Hospital

The Ontario government should fully fund the deficit of the Brockville General Hospital, hospital staff will request today, as they kick off a postcard campaign aimed at the provincial government.

19 Mar 2010

Role of structured physical activity in preventing or delaying mobility disabilities in older adults

Wake Forest University Baptist Medical Center, together with Wake Forest University, will play a key role in a new study that seeks to determine whether a program of structured physical activity can prevent or delay major mobility disabilities in older adults.

19 Mar 2010

New summit: Health care reform for children in California

“Why California’s Children Need Health Reform,” with special video remarks by U.S. Congresswoman Anna Eshoo.

19 Mar 2010

Northumberland Hills Hospital to lose vital services as a result of dramatic cuts to beds, services and staff

Vital services will be lost at the Northumberland Hills Hospital as a result of dramatic cuts to beds, services and staff, the union representing employees at the hospital charged today.

19 Mar 2010

Researchers use optogenetics technology to troubleshoot neural circuits

Recently, brain researchers have gained a powerful new way to troubleshoot neural circuits associated with depression, Parkinson's disease and other conditions in small animals such as rats. They use an optogenetics technology, invented at Stanford University, that precisely turns select brain cells on or off with flashes of light. Although useful, the optogenetics tool set has been limited.

19 Mar 2010

Stemedica files IND for trial using allogeneic mesenchymal bone marrow cells in patients with ischemic stroke

Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

Hospital News and Research

CIO Healthcare Summit to be sponsored by Zanett Healthcare

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

White paper describes health and economic burden of diabetes on Americans

European CHMP issues positive opinion for Roche's Tarceva as maintenance therapy for NSCLC

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

First Edition: March 19, 2010

Studies reveal increased polyp detection rates with TER during colonoscopy

New report on the state of U.S. mobile health market

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Despite recommendations, nearly 14% of Medicare beneficiaries with STEMI undergo multi-vessel PCI

Study shows that steroids target hemangioma stem cells

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Postcard campaign: Staff request Ontario government to fund deficit of Brockville General Hospital

Role of structured physical activity in preventing or delaying mobility disabilities in older adults

New summit: Health care reform for children in California

Northumberland Hills Hospital to lose vital services as a result of dramatic cuts to beds, services and staff

Researchers use optogenetics technology to troubleshoot neural circuits

Stemedica files IND for trial using allogeneic mesenchymal bone marrow cells in patients with ischemic stroke

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News